At MAD-ID, Alyssa Cox, PharmD, showed fidaxomicin reduces 90-day recurrence by 68.3% versus vancomycin, with rates of 7.9% vs. 19% in 176 hospitalized patients.
Alyssa Cox, PharmD
Advertisement
Clinical Pharmacist at Memorial Healthcare System in Tamarac, Florida.
Articles by Alyssa Cox, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
New Data Highlight Adult Pneumococcal Serotypes with Greater Antibiotic Resistance and Disease Burden Covered by Merck’s Vaccine
2
Developing a COVID-19 Vaccine Alternative
3
Oral Carbapenem Tebipenem HBr Demonstrates Non-Inferiority to IV Therapy in Phase III PIVOT-PO Trial
4
Generic Lenacapavir Could Cost as Little as $25 Per Person Annually
5
